Presentations

WATCH: RespireRx CSO Arnold Lippa Discusses Collaboration with University College London to Study Treatment Options for GRIA Disorders

WATCH: RespireRx CFO Jeff Margolis Shares Updates Following ResolutionRx Services Agreement with Australian CRO iNGENu

WATCH: RespireRx Pharmaceuticals Director Arnold Lippa Discusses R&D Financing Agreement with Radium Capital

WATCH: RespireRx Pharmaceuticals CFO Jeff Margolis Discusses Establishment of ResolutionRx subsidiary in Australia

WATCH: RespireRx Pharmaceuticals CFO Jeff Margolis Discusses New Letter of Intent with Australian Clinical Research Organization

11/10/22 – RespireRx Pharmaceuticals Inc. Investor Summit Q4 2022 Presentation

11/7/22 – A Translation Approach to Drug Discovery and Development: A Case Study with AMPAkines

9/7/22 – ResolutionRx Slide Deck Re-Purposing Dronabinol

WATCH: RespireRx Pharmaceuticals Research Fellow Jeff Witkin Discusses Newest GABAkine

WATCH: RespireRx CFO Jeff Margolis Shares 2021 Achievements and 2022 Outlook with Proactive Investors

Life Sciences Virtual Investor Conference Presentation December 2021

Biotech Showcase 2022 Presentation January 2022

WATCH: RespireRx President and CEO Tim Jones’ Pre-Recorded Video for Biotech Showcase 2022

11/08/21 – WATCH: RespireRx CFO Jeff Margolis Discusses Clinical Pipeline with Proactive Investors

06/08/21 – RespireRx Corporate Slide Deck Presented at June 2021 Access China Biotech Virtual Investor Conference
PDF Version
Video with Sound

05/12/21 – Poster presented at Annual Experimental Biology Conference April 2021

05/06/21 – RespireRx Summary Investor Deck May 2021

12/17/20 – RespireRx Corporate Slide Deck Q4 2020

11/12/20 – RespireRx November 2020 Slide Deck

03/09/20 – RespireRx Newco Presentation

02/05/20 – RespireRx Short Deck January 2020